结核与肺部疾病杂志2023年10月第4卷第5期JTubercLungDis,October2023,Vol.4,No.5.419.·综述·结核病治疗依从性状况、影响因素及干预措施研究进展阮淑金1曾坚²陈敬芳1.3【摘要】抗结核治疗需要长期、规范服用多种药物,这极易导致患者出现治疗不依从问题,影响其治疗结果。本文旨在对结核病患者治疗依从性现状、影响因素及干预策略等方面进行综述,以期为提高结核病患者治疗依从性提供参考依据。【关键词】结核;医院外治疗;病人依从;流行病学因素;干预性研究;综述文献(主题)【中图分类号】R52;R184Researchprogressontuberculosispatientstreatmentadherence:currentstatus,influencingfactors,andinterventionmeasures,RuanShujin',ZengJian’,ChenJingfang',WangXiufen,LiuLinlin',JiangYouli',LiMengjun'.ISchoolofNursing,SouthChinaUniversity,Hengyang421000,China;2DepartmentofPulmonaryMedicine,ShenzhenThirdPeople'sHospital,Shenzhen518112,China;'ResearchandTeachingDepartment,ShenzhenThirdPeople'sHospital,Shenzhen518112,China;*DepartmentofNeurology,LonghuaDistrictPeople'sHospital,Shenzhen518109,ChinaCorrespondingauthor:ChenJingfang,Email:13823139640@163.com[Abstract)Anti-tuberculosis(TB)treatmentrequireslong-term,regulatedadministrationofmultipledrugs,whichcaneasilyleadtonon-adherenceduringtreatmentandaffecttreatmentoutcomes.Thisarticleaimstoreviewthecurrentstatus,influencingfactorsandinterventionmeasuresoftreatmentadherenceofTBpatients,andprovidereferenceforimprovingtreatmentadherenceamongTBcases.【Keywords】Tuberculosis;Deinstitutionalization;Interventionstudies;Reviewliteratureastopic[Fundprogram]ShenzhenNaturalScienceFoundation(JCYJ20220530163403008)结核病的流行形势依然严峻,2021年全球新诊断结核病患者约为1060万例,而中国作为世界第三大结核病高负担国家,结核病患者占全球的7.4%[1]。患者抗结核治疗依从性不佳可引起治疗延迟和(或)治疗中断、病程延长、结核病复发、进展为耐药结核病,甚至治疗失败等,增加结核病的复发率和死亡率[2-3]。而提高结核病患者治疗依从性可开放科学(资源服务)标识码(OSID)的开放科学计划以二维码为入口,提供丰富的线上扩展功能,包括作者对论文背景的语音介绍、该研究的附加说明、与读者的交互问答、拓展学术圈等...